JW
Juncture Wealth Strategies, LLC
13F filer · CIK 0001632866Reported Jul 9, 2026
13F portfolio value$384MU.S. long equity reported on 13F
Positions109Not reported new · Not reported closed
Net flow last quarterNot reportedBuys minus sells
Top 10 positions weight7.9%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Jul 9, 2026109 positions | |||||
| $4.52M | 1.17% | Not reported | Not reported | Q4 2018 | |
| $3.68M | 0.96% | Not reported | Not reported | Q4 2014 | |
| $3.67M | 0.95% | Not reported | New | Q2 2026 | |
| $3.35M | 0.87% | 0.00% | Not reported | Q2 2024 | |
| $2.88M | 0.75% | 0.00% | Not reported | Q3 2021 | |
| $2.88M | 0.75% | 0.00% | Not reported | Q2 2019 | |
| $2.86M | 0.74% | Not reported | Not reported | Q4 2019 | |
| $2.86M | 0.74% | Not reported | Not reported | Q4 2025 | |
| $1.91M | 0.50% | 0.00% | Not reported | Q2 2017 | |
| $1.83M | 0.48% | 0.00% | Not reported | Q2 2021 | |
| $1.7M | 0.44% | 0.00% | Not reported | Q4 2014 | |
| $1.34M | 0.35% | 0.00% | New | Q2 2026 | |
| $1.29M | 0.34% | 0.17% | Not reported | Q4 2016 | |
| $1.29M | 0.34% | 0.00% | New | Q2 2026 | |
| $1.26M | 0.33% | 0.00% | Not reported | Q3 2025 | |
| $1.25M | 0.33% | 0.00% | Not reported | Q3 2021 | |
| $1.25M | 0.32% | 0.00% | Not reported | Q3 2025 | |
| $1.14M | 0.30% | Not reported | Not reported | Q3 2025 | |
| $1.13M | 0.29% | 0.00% | Not reported | Q3 2020 | |
| $1.08M | 0.28% | 0.00% | New | Q2 2026 | |
| $1.04M | 0.27% | 0.10% | Not reported | Q3 2025 | |
| $988K | 0.26% | 0.00% | Not reported | Q2 2022 | |
| $974K | 0.25% | Not reported | Not reported | Q2 2021 | |
| $929K | 0.24% | 0.01% | Not reported | Q1 2024 | |
| $904K | 0.24% | 0.00% | New | Q2 2026 | |
| $890K | 0.23% | 0.00% | Not reported | Q4 2021 | |
| $887K | 0.23% | 0.01% | Not reported | Q4 2023 | |
| $863K | 0.22% | 0.01% | Not reported | Q3 2025 | |
| $845K | 0.22% | 0.01% | Not reported | Q1 2024 | |
| $826K | 0.21% | 0.00% | Not reported | Q1 2024 | |
| $818K | 0.21% | 0.00% | Not reported | Q4 2023 | |
| $809K | 0.21% | 0.00% | New | Q2 2026 | |
| $806K | 0.21% | 0.00% | Not reported | Q4 2021 | |
| $786K | 0.20% | 0.00% | Not reported | Q1 2019 | |
| $768K | 0.20% | Not reported | Not reported | Q2 2023 | |
| $763K | 0.20% | 0.03% | New | Q2 2026 | |
| $734K | 0.19% | 0.00% | Not reported | Q4 2014 | |
| $710K | 0.18% | Not reported | Not reported | Q3 2021 | |
| $703K | 0.18% | 0.00% | New | Q2 2026 | |
| $681K | 0.18% | 0.00% | Not reported | Q2 2024 | |
| $674K | 0.18% | 0.00% | Not reported | Q3 2021 | |
| $635K | 0.17% | Not reported | Not reported | Q2 2024 | |
| $633K | 0.16% | 0.00% | New | Q2 2026 | |
| $618K | 0.16% | 0.00% | Not reported | Q2 2024 | |
| $618K | 0.16% | 0.01% | Not reported | Q3 2018 | |
| $608K | 0.16% | 0.00% | Not reported | Q4 2024 | |
| $581K | 0.15% | 0.03% | New | Q2 2026 | |
| CPCPRXCatalyst Pharmaceuticals, Inc. | $579K | 0.15% | 0.02% | Not reported | Q2 2023 |
| $564K | 0.15% | 0.01% | New | Q2 2026 | |
| $562K | 0.15% | 0.00% | New | Q2 2026 | |
| Q4 2025Reported Jan 27, 202671 positions | |||||
| $4.48M | 1.48% | Not reported | +1.0% | Q4 2018 | |
| $3.66M | 1.21% | Not reported | -6.5% | Q4 2014 | |
| $2.85M | 0.94% | 0.03% | -2.9% | Q1 2018 | |
| $2.13M | 0.70% | 0.00% | -5.5% | Q2 2017 | |
| $1.98M | 0.65% | 0.00% | -7.5% | Q3 2021 | |
| CPCPRXCatalyst Pharmaceuticals, Inc. | $1.97M | 0.65% | 0.07% | +1.1% | Q2 2023 |
| $1.76M | 0.58% | Not reported | -12.4% | Q4 2019 | |
| $1.37M | 0.45% | 0.18% | -7.4% | Q4 2016 | |
| $1.25M | 0.41% | 0.00% | -6.3% | Q2 2024 | |
| $1.16M | 0.38% | 0.00% | +0.9% | Q4 2014 | |
| $1.14M | 0.37% | 0.00% | +17.3% | Q2 2022 | |
| $1.02M | 0.34% | 0.00% | -6.8% | Q2 2021 | |
| $977K | 0.32% | Not reported | -4.5% | Q2 2021 | |
| $939K | 0.31% | Not reported | -11.0% | Q3 2021 | |
| $871K | 0.29% | Not reported | -6.4% | Q2 2023 | |
| $791K | 0.26% | 0.00% | +0.3% | Q3 2021 | |
| $788K | 0.26% | 0.01% | +4.6% | Q1 2024 | |
| $739K | 0.24% | 0.01% | -1.3% | Q1 2024 | |
| $737K | 0.24% | 0.00% | +32.7% | Q1 2019 | |
| $721K | 0.24% | 0.00% | -9.4% | Q1 2024 | |
| $680K | 0.22% | 0.00% | +2.7% | Q4 2023 | |
| $624K | 0.21% | 0.00% | +7.8% | Q1 2024 | |
| $603K | 0.20% | 0.00% | +21.2% | Q3 2021 | |
| $598K | 0.20% | 0.00% | +8.0% | Q2 2024 | |
| $575K | 0.19% | 0.00% | Not reported | Q2 2024 | |
| $557K | 0.18% | 0.00% | -0.4% | Q1 2019 | |
| $543K | 0.18% | 0.00% | -1.0% | Q4 2024 | |
| $508K | 0.17% | Not reported | +7.9% | Q2 2024 | |
| $481K | 0.16% | 0.01% | +19.9% | Q2 2023 | |
| CCMAComerica Inc | $477K | 0.16% | 0.00% | +17.1% | Q3 2025 |
| $423K | 0.14% | 0.00% | +9.0% | Q2 2024 | |
| $411K | 0.14% | 0.00% | Not reported | Q2 2023 | |
| $405K | 0.13% | 0.00% | -4.7% | Q3 2025 | |
| $392K | 0.13% | 0.00% | -22.3% | Q1 2024 | |
| $380K | 0.13% | 0.00% | +10.9% | Q3 2019 | |
| $358K | 0.12% | 0.00% | +23.2% | Q3 2025 | |
| $356K | 0.12% | Not reported | +31.6% | Q3 2025 | |
| $355K | 0.12% | 0.00% | +39.0% | Q3 2022 | |
| $355K | 0.12% | 0.01% | +13.9% | Q3 2025 | |
| $342K | 0.11% | Not reported | New | Q4 2025 | |
| $336K | 0.11% | Not reported | +18.7% | Q3 2025 | |
| $325K | 0.11% | 0.00% | -0.1% | Q4 2022 | |
| $321K | 0.11% | 0.07% | +12.0% | Q3 2025 | |
| $307K | 0.10% | 0.00% | 0.0% | Q4 2014 | |
| $307K | 0.10% | 0.01% | -1.3% | Q4 2024 | |
| $302K | 0.10% | 0.00% | +23.5% | Q3 2025 | |
| $300K | 0.10% | 0.00% | -7.4% | Q4 2022 | |
| $295K | 0.10% | 0.00% | -11.5% | Q1 2015 | |
| $294K | 0.10% | 0.00% | Not reported | Q4 2022 | |
| $288K | 0.09% | 0.00% | -5.1% | Q4 2022 | |
| Q3 2025Reported Oct 14, 202570 positions | |||||
| $4.34M | 1.45% | Not reported | -2.2% | Q4 2018 | |
| $4.12M | 1.38% | Not reported | -12.0% | Q4 2014 | |
| $3.19M | 1.07% | 0.04% | -3.0% | Q1 2018 | |
| $2.84M | 0.95% | 0.01% | -0.2% | Q2 2017 | |
| $2.14M | 0.72% | 0.00% | -1.8% | Q3 2021 | |
| $1.73M | 0.58% | Not reported | -4.6% | Q4 2019 | |
| CPCPRXCatalyst Pharmaceuticals, Inc. | $1.64M | 0.55% | 0.07% | -8.7% | Q2 2023 |
| $1.48M | 0.50% | 0.20% | +9.5% | Q4 2016 | |
| $1.27M | 0.43% | 0.00% | -0.2% | Q2 2024 | |
| $1.17M | 0.39% | 0.00% | -2.6% | Q2 2021 | |
| $1.17M | 0.39% | Not reported | -1.2% | Q3 2021 | |
| $1.02M | 0.34% | Not reported | +2.7% | Q2 2021 | |
| $1.02M | 0.34% | 0.00% | +1.0% | Q4 2014 | |
| $987K | 0.33% | 0.00% | +42.3% | Q2 2022 | |
| $923K | 0.31% | 0.00% | -1.5% | Q1 2024 | |
| $815K | 0.27% | 0.01% | +5.5% | Q1 2024 | |
| $780K | 0.26% | 0.00% | +3.5% | Q3 2021 | |
| $723K | 0.24% | Not reported | -8.3% | Q2 2023 | |
| $656K | 0.22% | 0.00% | +17.2% | Q4 2023 | |
| $614K | 0.21% | 0.01% | +20.9% | Q2 2020 | |
| $593K | 0.20% | 0.00% | -2.3% | Q2 2023 | |
| $567K | 0.19% | 0.00% | Not reported | Q2 2024 | |
| $535K | 0.18% | 0.00% | +9.5% | Q1 2024 | |
| $533K | 0.18% | 0.00% | +10.8% | Q2 2024 | |
| $506K | 0.17% | 0.00% | -41.2% | Q1 2019 | |
| $494K | 0.17% | 0.01% | +17.8% | Q1 2024 | |
| $486K | 0.16% | 0.00% | -46.3% | Q4 2024 | |
| $481K | 0.16% | 0.00% | +8.0% | Q1 2024 | |
| $466K | 0.16% | 0.00% | +80.4% | Q3 2021 | |
| $460K | 0.15% | Not reported | +40.7% | Q2 2024 | |
| $458K | 0.15% | 0.00% | Not reported | Q1 2019 | |
| $431K | 0.14% | 0.00% | New | Q3 2025 | |
| $427K | 0.14% | 0.01% | Not reported | Q2 2023 | |
| $387K | 0.13% | 0.00% | New | Q3 2025 | |
| $375K | 0.13% | 0.00% | +16.8% | Q2 2024 | |
| $372K | 0.12% | 0.00% | +15.1% | Q3 2019 | |
| $369K | 0.12% | 0.06% | New | Q3 2025 | |
| $368K | 0.12% | 0.05% | Not reported | Q2 2023 | |
| $353K | 0.12% | 0.00% | -0.1% | Q4 2022 | |
| $339K | 0.11% | 0.00% | +15.7% | Q4 2022 | |
| $337K | 0.11% | 0.00% | -37.6% | Q2 2024 | |
| $332K | 0.11% | 0.01% | Not reported | Q4 2024 | |
| $329K | 0.11% | 0.00% | New | Q3 2025 | |
| $326K | 0.11% | 0.00% | -27.9% | Q1 2017 | |
| $325K | 0.11% | 0.00% | -15.5% | Q1 2015 | |
| CCMAComerica Inc | $321K | 0.11% | 0.00% | New | Q3 2025 |
| $319K | 0.11% | 0.01% | Not reported | Q2 2024 | |
| $308K | 0.10% | 0.00% | -27.4% | Q1 2025 | |
| $291K | 0.10% | 0.00% | 0.0% | Q4 2014 | |
| $288K | 0.10% | 0.00% | New | Q3 2025 | |
| Q2 2025Reported Jul 8, 202566 positions | |||||
| $4.54M | 1.61% | Not reported | -12.2% | Q4 2014 | |
| $4.11M | 1.46% | Not reported | +0.8% | Q4 2018 | |
| $3.29M | 1.17% | 0.01% | -4.4% | Q2 2017 | |
| $2.13M | 0.76% | 0.04% | -1.3% | Q1 2018 | |
| CPCPRXCatalyst Pharmaceuticals, Inc. | $1.98M | 0.70% | 0.07% | -5.0% | Q2 2023 |
| $1.85M | 0.66% | 0.00% | -4.6% | Q3 2021 | |
| $1.35M | 0.48% | 0.18% | -0.4% | Q4 2016 | |
| $1.22M | 0.43% | Not reported | +5.2% | Q4 2019 | |
| $1.19M | 0.42% | Not reported | +2.9% | Q3 2021 | |
| $1.16M | 0.41% | 0.00% | -3.2% | Q2 2021 | |
| $1.06M | 0.38% | 0.00% | -4.9% | Q2 2024 | |
| $1.05M | 0.37% | 0.00% | -2.2% | Q1 2024 | |
| $1.02M | 0.36% | 0.00% | +0.9% | Q4 2014 | |
| $963K | 0.34% | Not reported | -1.5% | Q2 2021 | |
| $860K | 0.31% | 0.00% | -9.0% | Q1 2019 | |
| $702K | 0.25% | 0.00% | Not reported | Q4 2024 | |
| $639K | 0.23% | 0.00% | +8.3% | Q2 2022 | |
| $574K | 0.20% | Not reported | +6.0% | Q2 2023 | |
| $548K | 0.19% | 0.01% | -15.0% | Q1 2024 | |
| $538K | 0.19% | 0.00% | -30.5% | Q1 2017 | |
| $538K | 0.19% | 0.00% | +25.0% | Q3 2021 | |
| $534K | 0.19% | 0.00% | Not reported | Q2 2024 | |
| $515K | 0.18% | 0.00% | -2.3% | Q1 2024 | |
| $501K | 0.18% | 0.00% | -41.0% | Q4 2023 | |
| $501K | 0.18% | 0.01% | -36.4% | Q2 2020 | |
| $479K | 0.17% | 0.00% | Not reported | Q4 2023 | |
| $472K | 0.17% | 0.00% | +0.1% | Q2 2023 | |
| $453K | 0.16% | 0.00% | Not reported | Q2 2024 | |
| $449K | 0.16% | 0.01% | +10.4% | Q2 2020 | |
| $446K | 0.16% | 0.00% | +4.3% | Q2 2024 | |
| $432K | 0.15% | 0.01% | -28.9% | Q1 2024 | |
| $425K | 0.15% | Not reported | -35.2% | Q1 2024 | |
| $418K | 0.15% | 0.00% | +109.8% | Q1 2025 | |
| $411K | 0.15% | 0.00% | 0.0% | Q1 2024 | |
| $392K | 0.14% | 0.00% | +2.2% | Q4 2024 | |
| $381K | 0.14% | 0.00% | Not reported | Q4 2022 | |
| $379K | 0.13% | 0.00% | +5.5% | Q1 2024 | |
| $369K | 0.13% | 0.00% | Not reported | Q2 2024 | |
| $355K | 0.13% | 0.00% | +7.4% | Q1 2015 | |
| $348K | 0.12% | 0.00% | +4.9% | Q2 2024 | |
| $341K | 0.12% | 0.01% | Not reported | Q4 2024 | |
| $329K | 0.12% | 0.00% | -21.4% | Q3 2019 | |
| $326K | 0.12% | 0.00% | +0.1% | Q1 2015 | |
| $311K | 0.11% | 0.00% | 0.0% | Q4 2014 | |
| $293K | 0.10% | 0.00% | Not reported | Q2 2024 | |
| $292K | 0.10% | Not reported | -8.2% | Q4 2024 | |
| $292K | 0.10% | 0.00% | Not reported | Q4 2022 | |
| $287K | 0.10% | 0.00% | Not reported | Q4 2015 | |
| $281K | 0.10% | 0.00% | Not reported | Q2 2021 | |
| $267K | 0.10% | 0.00% | Not reported | Q2 2024 | |
Premium opens every quarter this fund has filed